Abstract
Glycogen storage disease type 1b (GSD 1b) is caused by mutations in the Glucose-6-phosphate transporter and is characterized by impaired glucose homeostasis. In addition, GSD-1b is associated with chronic neutropenia resulting in recurrent infections and inflammatory bowel disease. It is unclear whether the neutropenia is solely due to enhanced apoptosis of mature neutrophils or whether aberrant neutrophil development may also contribute. Here we demonstrate that hematopoietic progenitors from GSD-1b patients are not impaired in their capacity to develop into mature neutrophils. However, optimal survival of neutrophil progenitors from GSD-1b patients requires high glucose levels (> 200 mg dl−1), suggesting that even under normoglycemic conditions these cells are more prone to apoptosis. Furthermore, analysis of cytokine levels in peripheral blood suggests an inflammatory state with an inverse correlation between the level of inflammation and the number of neutrophils. Finally, in some patients, with low numbers of peripheral blood neutrophils, high numbers of neutrophils were observed in the intestine. Together, these results suggest that the neutropenia observed in GSD-1b patients is not caused by impaired maturation, but may be caused by both increased levels of apoptosis and egress of neutrophils from the blood to the inflamed tissues.
Similar content being viewed by others
References
Adachi M, Shinkai M, Ohhama Y et al. (2004) Improved neutrophil function in a glycogen storage disease type 1b patient after liver transplantation. Eur J Pediatr 163:202–206
Ambruso DR, McCabe ER, Anderson D et al. (1985) Infectious and bleeding complications in patients with glycogenosis Ib. Am J Dis Child 139:691–697
Annabi B, Hiraiwa H, Mansfield BC et al. (1998) The gene for glycogen-storage disease type 1b maps to chromosome 11q23. Am J Hum Genet 62:400–405
Arion WJ, Lange AJ, Walls HE, Ballas LM (1980) Evidence for the participation of independent translocation for phosphate and glucose 6-phosphate in the microsomal glucose-6-phosphatase system. Interactions of the system with orthophosphate, inorganic pyrophosphate, and carbamyl phosphate. J Biol Chem 255:10396–10406
Boztug K, Appaswamy G, Ashikov A et al. (2009) A syndrome with congenital neutropenia and mutations in G6PC3. N Engl J Med 360:32–43
Calderwood S, Kilpatrick L, Douglas SD et al. (2001) Recombinant human granulocyte colony-stimulating factor therapy for patients with neutropenia and/or neutrophil dysfunction secondary to glycogen storage disease type 1b. Blood 97:376–382
Chen LY, Shieh JJ, Lin B et al. (2003) Impaired glucose homeostasis, neutrophil trafficking and function in mice lacking the glucose-6-phosphate transporter. Hum Mol Genet 12:2547–2558
Chou JY, Jun HS, Mansfield BC (2010) Neutropenia in type Ib glycogen storage disease. Curr Opin Hematol 17:36–42
de Jager W, Prakken BJ, Bijlsma JW, Kuis W, Rijkers GT (2005) Improved multiplex immunoassay performance in human plasma and synovial fluid following removal of interfering heterophilic antibodies. J Immunol Methods 300:124–135
de Jager W, Bourcier K, Rijkers GT, Prakken BJ, Seyfert-Margolis V (2009) Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays. BMC Immunol 10:52
Foster JD, Nordlie RC (2002) The biochemistry and molecular biology of the glucose-6-phosphatase system. Exp Biol Med (Maywood) 227:601–608
Gitzelmann R, Bosshard NU (1993) Defective neutrophil and monocyte functions in glycogen storage disease type Ib: a literature review. Eur J Pediatr 152(Suppl 1):S33–S38
Guionie O, Clottes E, Stafford K, Burchell A (2003) Identification and characterisation of a new human glucose-6-phosphatase isoform. FEBS Lett 551:159–164
Hayee B, Antonopoulos A, Murphy EJ et al. (2011) G6PC3 mutations are associated with a major defect of glycosylation: a novel mechanism for neutrophil dysfunction. Glycobiology 21:914–924
Jun HS, Lee YM, Cheung YY et al. (2010) Lack of glucose recycling between endoplasmic reticulum and cytoplasm underlies cellular dysfunction in glucose-6-phosphatase-beta-deficient neutrophils in a congenital neutropenia syndrome. Blood 116:2783–2792
Jun HS, Lee YM, Song KD et al. (2011) G-CSF improves murine G6PC3-deficient neutrophil function by modulating apoptosis and energy homeostasis. Blood 117:3881–3892
Kasahara M, Horikawa R, Sakamoto S et al. (2009) Living donor liver transplantation for glycogen storage disease type Ib. Liver Transpl 15:1867–1871
Kilpatrick L, Garty BZ, Lundquist KF et al. (1990) Impaired metabolic function and signaling defects in phagocytic cells in glycogen storage disease type 1b. J Clin Invest 86:196–202
Kim SY, Nguyen AD, Gao JL, Murphy PM, Mansfield BC, Chou JY (2006) Bone marrow-derived cells require a functional glucose 6-phosphate transporter for normal myeloid functions. J Biol Chem 281:28794–28801
Kim SY, Jun HS, Mead PA, Mansfield BC, Chou JY (2008) Neutrophil stress and apoptosis underlie myeloid dysfunction in glycogen storage disease type Ib. Blood 111:5704–5711
Kuijpers TW, Maianski NA, Tool AT et al. (2003) Apoptotic neutrophils in the circulation of patients with glycogen storage disease type 1b (GSD1b). Blood 101:5021–5024
Lei KJ, Shelly LL, Lin B et al. (1995) Mutations in the glucose-6-phosphatase gene are associated with glycogen storage disease types 1a and 1aSP but not 1b and 1c. J Clin Invest 95:234–240
Leuzzi R, Banhegyi G, Kardon T et al. (2003) Inhibition of microsomal glucose-6-phosphate transport in human neutrophils results in apoptosis: a potential explanation for neutrophil dysfunction in glycogen storage disease type 1b. Blood 101:2381–2387
McCawley LJ, Korchak HM, Douglas SD et al. (1994) In vitro and in vivo effects of granulocyte colony-stimulating factor on neutrophils in glycogen storage disease type 1B: granulocyte colony-stimulating factor therapy corrects the neutropenia and the defects in respiratory burst activity and Ca2+ mobilization. Pediatr Res 35:84–90
Petty JM, Lenox CC, Weiss DJ, Poynter ME, Suratt BT (2009) Crosstalk between CXCR4/stromal derived factor-1 and VLA-4/VCAM-1 pathways regulates neutrophil retention in the bone marrow. J Immunol 182:604–612
Rake JP, Visser G, Labrune P, Leonard JV, Ullrich K, Smit GP (2002a) Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I). Eur J Pediatr 161(Suppl 1):S20–S34
Rake JP, Visser G, Labrune P et al. (2002b) Guidelines for management of glycogen storage disease type I - European Study on Glycogen Storage Disease Type I (ESGSD I). Eur J Pediatr 161(Suppl 1):S112–S119
Verhoeven AJ, Visser G, van Zwieten R, Gruszczynska B, Tien Poll-The DW, Smit GP (1999) A convenient diagnostic function test of peripheral blood neutrophils in glycogen storage disease type Ib. Pediatr Res 45:881–885
Visser G, Rake JP, Fernandes J et al. (2000) Neutropenia, neutrophil dysfunction, and inflammatory bowel disease in glycogen storage disease type Ib: results of the European Study on Glycogen Storage Disease type I. J Pediatr 137:187–191
Visser G, Rake JP, Kokke FT et al. (2002a) Intestinal function in glycogen storage disease type I. J Inherit Metab Dis 25:261–267
Visser G, Rake JP, Labrune P et al. (2002b) Granulocyte colony-stimulating factor in glycogen storage disease type 1b. Results of the European Study on Glycogen Storage Disease Type 1. Eur J Pediatr 161(Suppl 1):S83–S87
Acknowledgements
M.B. was supported by ZonMW (Veni 916.76.137).
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by: Alberto B. Burlina
Competing interest: None declared.
Gepke Visser, Wilco de Jager, contributed equally.
Rights and permissions
About this article
Cite this article
Visser, G., de Jager, W., Verhagen, L.P. et al. Survival, but not maturation, is affected in neutrophil progenitors from GSD-1b patients. J Inherit Metab Dis 35, 287–300 (2012). https://doi.org/10.1007/s10545-011-9379-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-011-9379-4